Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 8/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL665501 | 0.86 | TSHR (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL17922841 | 0.82 | TSHR (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL12394810 | 0.81 | ALDH1A1 (0.48) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL663437 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL8731570 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL665663 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL28520107 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL9229975 | 0.80 | TSHR (0.56) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL21066641 | 0.78 | TSHR (0.55) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL29026109 | 0.78 | THRB (0.49) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115895353-A | Preparation method of FEVE coating | 江苏考普乐新材料股份有限公司 | 2023-04-04 | — | — | CN | claimed |
| US-8865851-B2 | Moisture-curing coating compositions comprising aprotic solvents and binders having alkoxysilane groups and method of forming a multicoat finish therewith | BASF COATINGS GMBH (DE) | 2014-10-21 | — | — | US | claimed |
| EP-2414466-B1 | MOISTURE-CURING COATING COMPOSITIONS BASED ON APROTIC SOLVENTS, COMPRISING BINDERS HAVING ALKOXYSILANE GROUPS, AND THE USE THEREOF | BASF COATINGS GMBH (DE) | 2013-10-16 | — | — | EP | claimed |
| US-20120045586-A1 | MOISTURE-CURING COATING COMPOSITIONS BASED ON APROTIC SOLVENTS COMPRISING BINDERS HAVING ALKOXYSILANE GROUPS AND THE USE THEREOF | BASF COATINGS GMBH (DE) | 2012-02-23 | — | — | US | claimed |
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | claimed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| CN-117983518-A | Method for manufacturing laminated structure and use thereof | 株式会社钟化 | 2024-05-07 | — | — | CN | disclosed |
| CN-115975444-A | FEVE coating | 江苏考普乐新材料股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115895353-A | Preparation method of FEVE coating | 江苏考普乐新材料股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-112424269-B | Resin composition for foam, and method for producing foam | 株式会社钟化 | 2023-02-28 | — | — | CN | disclosed |
| EP-3392036-B1 | METHOD FOR PRODUCING LAMINATE, AND LAMINATE | KANEKA CORP (JP) | 2022-03-30 | — | — | EP | disclosed |
| CN-109803826-B | Laminate and method for producing same | 信越化学工业株式会社 | 2021-05-11 | — | — | CN | disclosed |
| CN-108472685-B | Method for producing laminate | 信越化学工业株式会社 | 2021-02-02 | — | — | CN | disclosed |
| EP-3045506-A1 | ACTINIC ENERGY RADIATION-CURABLE ACRYLIC SILICONE RESIN COMPOSITION AND COATED ARTICLE | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-07-20 | — | — | EP | disclosed |
| US-20150337159-A1 | One-Component, Curable Coating Compositions, Processes For Making And Using Them, And Coatings And Articles Prepared With Them | BASF COATINGS GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| EP-2941460-A1 | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF Coatings GmbH (DE) | 2015-11-11 | — | — | EP | disclosed |
| CN-104884552-A | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF COATINGS GMBH | 2015-09-02 | — | — | CN | disclosed |
| US-8865851-B2 | Moisture-curing coating compositions comprising aprotic solvents and binders having alkoxysilane groups and method of forming a multicoat finish therewith | BASF COATINGS GMBH (DE) | 2014-10-21 | — | — | US | disclosed |
| WO-2014106552-A1 | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF COATINGS GMBH (DE) | 2014-07-10 | — | — | WO | disclosed |
| US-20120045586-A1 | MOISTURE-CURING COATING COMPOSITIONS BASED ON APROTIC SOLVENTS COMPRISING BINDERS HAVING ALKOXYSILANE GROUPS AND THE USE THEREOF | BASF COATINGS GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | ALDH1A1 402/4885TP53 4663/4885HIF1A 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.